Prednisone (Oral Steroids)
A corticosteroid medication used to reduce inflammation in many neuro-ophthalmic conditions.
Drug Class: Corticosteroids
Prednisone is an oral corticosteroid medication used to treat inflammation. In neuro-ophthalmology, it's used for conditions like giant cell arteritis, optic neuritis, thyroid eye disease, and other inflammatory conditions.
Key Takeaways
- Reduces inflammation by suppressing immune activity
- Used for many neuro-ophthalmic conditions
- Requires careful monitoring for side effects
- Tapering required-don't stop suddenly
- Long-term use carries significant risks
How It Works
Prednisone is converted to prednisolone in the body. It suppresses the immune system and reduces inflammation by blocking inflammatory chemicals and reducing immune cell activity.
Common Uses in Neuro-Ophthalmology
- Giant cell arteritis-high doses to prevent blindness
- Optic neuritis-oral taper after IV steroids
- Thyroid eye disease
- Myasthenia gravis
- MOGAD and NMO
- Other inflammatory conditions
Dosing
- Varies widely depending on condition
- High-dose for GCA (40-60mg daily or higher)
- Tapered gradually-never stop suddenly
- Your doctor will provide specific instructions
Long-Term Treatment Guide
If you're on long-term prednisone therapy, see our comprehensive guide for managing side effects, monitoring your health, and understanding tapering: Living with Long-Term Steroid Treatment - Patient Guide.
Side Effects
Common
- Increased appetite, weight gain
- Mood changes, insomnia
- Elevated blood sugar
- Increased blood pressure
- Fluid retention
With Prolonged Use
- Osteoporosis (bone thinning)
- Cataracts
- Increased infection risk
- Skin thinning, easy bruising
- Muscle weakness
- Adrenal suppression
Monitoring
- Blood pressure
- Blood sugar
- Bone density (with long-term use)
- Eye examinations (cataract risk)
- Infection symptoms, even if fever is muted
- Stomach protection, sleep, mood, and bone-health prevention when treatment will last more than a brief course
Important Precautions
Never stop prednisone suddenly after taking it for more than a few weeks. Your body needs time to resume its own cortisol production. Sudden stopping can cause serious problems.
Pregnancy and Breastfeeding
Tell the prescribing doctor if you are pregnant, planning pregnancy, or breastfeeding. Prednisone may still be appropriate when untreated inflammation could threaten vision or health, but pregnancy dosing should be coordinated with obstetrics, and infants exposed to substantial maternal doses may need newborn monitoring for adrenal suppression. During breastfeeding, LactMed reports very low milk levels and no reported adverse infant effects with maternal corticosteroid use; medium or large systemic doses can sometimes reduce milk supply, so ask whether timing feeds or infant monitoring is needed for your dose.
Frequently Asked Questions
How long will I need to take this?
Duration varies by condition. Some conditions require only short courses, while others (like GCA) may require months to years of treatment.
Why do I need to taper slowly?
Long-term steroid use suppresses your body's natural cortisol production. Tapering allows your adrenal glands to resume normal function gradually.
Can I take other medications with prednisone?
Many drug interactions exist. Always inform your doctor of all medications, including over-the-counter drugs and supplements.
Why am I asked about vaccines and infections?
Prednisone suppresses immune responses and can hide fever or other warning signs. Before long-term treatment, your clinician may review vaccines, tuberculosis or hepatitis risk, and whether any active infection needs treatment first.
Medical Disclaimer: This information is for educational purposes only and does not replace professional medical advice.
Sources:
- DailyMed. Prednisone tablets prescribing information.
- LactMed. Prednisone.
- American College of Rheumatology. Giant Cell Arteritis.
- Maz M, et al. 2021 American College of Rheumatology/Vasculitis Foundation guideline for the management of giant cell arteritis and Takayasu arteritis. Arthritis Rheumatol. 2021;73(8):1349-1365.
